News, funding, event and opportunities from the combined networks of TCRN, CONCERT and the Cancer Clinical Academic Group.

Vision: Uniting cancer research into a globally-leading partnership to deliver continuing evidence-based practice in diagnosis, intervention, and support.

Subscribe here.

LATEST NEWS

 HSA Biobank celebrates patient consent milestone 

This month marks a significant milestone for one of the most valuable translational research resources in NSW. The Health Science Alliance (HSA) Biobank has reached over 4,000 consents.

Read more

SPHERE – MRFF Rapid Applied Research Translation Funding EOI Process 

The MRFF RART funding scheme makes $27.5M available to organisations like SPHERE for grants of between $250K and $10M to be paid over 3 years for projects of up to 5 years duration. Universities, MRIs and certain other incorporated entities can submit ONE application each and investigators named on ONE application only. 
 
SPHERE is managing a rapid Expression of Interest process for this opportunity to assist its 16 Clinical Academic Groups and 14 partner organisations to short-list, coordinate and uplift applications with the greatest potential for success. All eligible applications will be assessed by an expert review panel and SPHERE Executive members will liaise with successful EOI applicants about progressing to full applications to be submitted by our eligible partner organisations. 

You are strongly encouraged to participate in this EOI process if submitting a RART application. Please contact Dr Adam Walczak with any enquires and see the link to the EOI form (recently updated version) below.
 
EOI Deadline: 10 March 2021 (11.59 PM); CIs notified of outcome 24 March 2021
MRFF RART Round 3 Deadline: 6 May 2021

EOI Form 

MRFF Roadmap and Implementation Plans consultation

Consultation is open to inform the development of six MRFF research missions Roadmaps and Implementation Plans. You can provide feedback at the following Expert Advisory Panels hosted webinars:
•    Cardiovascular Health Mission webinars on 23 February 2021 and 10 March 2021 
•    Dementia, Ageing and Aged Care Mission webinars on 16 February 2021 and 19 March 2021
•    Genomics Health Futures Mission webinars on 16 March 2021 and 25 March 2021
•    Indigenous Health Research Fund webinars on 23 March 2021 and 30 March 2021
•    Stem Cell Therapies Mission webinars on 11 March 2021 and 26 March 2021
•    Traumatic Brain Injury Mission webinars on 19 February 2021 and 5 March 2021

Written submissions for all consultations close on  23 April 2021.

GRANTS 

Global Innovation Linkages Program

The Global Innovation Linkages Program (round 3) provides funding to help Australian businesses and researchers collaborate with global partners. Priority areas include medical technologies and pharmaceuticals. 

Deadline: 7 April 2021

Read more

MRFF Funding Opportunities

• MRFF – EPCDR Initiative– 2020 Improving Diagnosis in Cancers with Low Survival Rates Grant Opportunity Deadline: 10 March 2021
• MRFF – Emerging Priorities and Consumer Driven Research Initiative – 2020 Paediatric Cancer Grant Opportunity Deadline: 10 March 2021
• MRFF EPCDR Initiative – 2020 Neurofibromatosis Research Grant Deadline: 7 April 2021

NHMRC 2021 Funding Opportunities

• 2021 Investigator Grants Deadline: 31 March 2021
• Partnership Project 2021 PRC1 Deadline: 7 April 2021
• 2021 Synergy Grants Deadline: 21 April 2021
• 2021 Ideas Grants Deadline: 5 May 2021

AWARDS, TRAINING AND RESOURCES

Webinar: Publishing your Research - Publish or Perish?

This session for health professionals who are considering or planning to publish their work. It will outline the publication and peer review processes, how to respond to feedback and common errors in journal submissions.

When: 3 March 2021

Read more

Guidelines and Impact: the art of storytelling

This webinar, will describe ways in which you can use data and present impact through case studies.

When: 12 March 2021

Read more

SEMINARS AND EVENTS

Inferior: Caroline Ford in conversation with Angela Saini 

British science journalist and author, Angela Saini, joins leading cancer researcher Caroline Ford for a conversation about bias in science, medicine and the public understanding of gender, and how to build a more accurate picture of human difference.

When: 8 March 2021 (International Women's Day)

Read more

PaCCSC and CST Annual Research Forum 2021

The PaCCSC and CST Annual Research Forum supports new study ideas, networking opportunities and collaborations. This year's theme is Clinical trials in a changing world, featuring clinical trials experts including keynote speaker, Dr R. Sean Morrison, Director of the National Palliative Care Research Center, New York. 

When: 11 - 12 March 2021

Read more

Harnessing the immune system against pancreatic cancer 

This Garvan Institute ‘Bite Size Science'  public seminar is presented by A/Prof Marina Pajic via Zoom. Book to attend. 

When: 18 March 2021

Read more

Australian Polygenic risk symposium

The second Australian Polygenic Risk Symposium will held virtually, bringing together researchers, clinicians, educators and industry to focus on the applications of polygenic risk and its clinical implementation.

When: 20 - 22 April 2021

Read more

ABOUT US

TCRN
The Translational Cancer Research Network (TCRN) is a translational cancer research centre program funded by the Cancer Institute NSW and is a collaborative and interactive cancer research community based in the South East of Sydney, with links to cancer services and researchers in inner and southern Sydney, and Albury. It was formed to create an innovative and supportive environment for the translation of cancer research into improvements in patient care.

CONCERT
The Centre for Oncology Education, Research and Training (CONCERT) is a translational research centre program funded by the Cancer Insitute NSW. CONCERT exists to bring together the knowledge and expertise of cancer health professionals and researchers to facilitate translation of research generated evidence into practice to achieve better outcomes for those affected by cancer.

Cancer CAG
The Cancer Clinical Academic Group (Cancer CAG) brings together clinicians and researchers from three universities, four cancer services (with six major treatment facilities) and three Medical Research Institutes. Our combined research strength spans the translational medicine spectrum of bench to bedside and health service delivery.

Working with TCRC partners, our network extends to all of the organisations below.

Connect with us